Tamoxifen 10mg
Babytam is the 5-mg daily dose of tamoxifen being studied in the ongoing TAM study, which is investigating incidence of invasive breast cancer or ductal carcinoma in situ among high-risk women who have received the treatment regimen for 3 years.